| CAPACITY |
Patentee's Co.'s 450,000-sq-ft production facility for erythro poietin won FDA approval in 07.00, tripling Co.'s capacity |
| CLASSIFICATION | CommPat. Market |
| INDICATION'S |
Anemia associated with - Kidney dialysis |
| LEGAL DISPUTES |
In dispute between Patentee Co. & Firms No. 1 & 2 (See Company); PATENTEE CO. PREVAILS. - Judge Young's decision actually was mixed, finding that 2 of 5 Patentee's patents on Erythropoietin production WERE NOT infringed & only CERTAIN CLAIMS of the others were None of the patents was invalidated Co.'s 1 & 2 said they will appeal. Industry analysts are skep tical obout Co. No. 2 chances |
| MARKETER'S COUNTRY | USA |
| PATENT ASSIGNEE'S COUNTRY | USA |
| PRODUCER'S COUNTRY | USA |
| SALES VALUE | U.S. sales value last year = US$ 1.96 billion |
| TECHNOLOGY | Recombinant technology |
| UPDATE | 01.01 |
| COMPANY | This data is not available for free |
| MARKETING BY | This data is not available for free |
| PATENT ASSIGNEE | This data is not available for free |
| PRODUCTION BY | This data is not available for free |
| TRADEMARK | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |